Pulmatrix (PULM) Current Assets (2014 - 2026)
Pulmatrix (PULM) posted Current Assets of $4.5 million for Q1 2026, up 8.72% sequentially from $4.1 million in Q4 2025, and down 44.17% YoY from $8.0 million in Q1 2025.
Pulmatrix (PULM) Current Assets (2014 - 2026) Analysis & Trends
Pulmatrix has reported Current Assets for 13 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Current Assets fell 44.17% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 44.17% YoY) and the FY2025 annual result came in at $4.1 million, down 58.38% from the prior year.
- Current Assets grew to $4.5 million in Q1 2026 per PULM's latest filing, from $4.1 million in the prior quarter.
- Over five years, Current Assets peaked at $50.6 million in Q1 2022 and troughed at $4.1 million in Q4 2025.
- A 5-year average of $21.4 million and a median of $17.6 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets fell 20.6% in 2022, then plunged 60.72% in 2025.
- Over 5 years, Current Assets stood at $38.1 million in 2022, then tumbled by 45.36% to $20.8 million in 2023, then tumbled by 52.41% to $9.9 million in 2024, then sank by 58.38% to $4.1 million in 2025, then advanced by 8.72% to $4.5 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $4.5 million, $4.1 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 1.76 Bn |
| 10 | Pulmatrix | 5.62 Mn | 5.62 Mn | - | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | 4.13 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Dec 31, 2024 | 9.92 Mn |
| Sep 30, 2024 | 11.45 Mn |
| Jun 30, 2024 | 15.64 Mn |
| Mar 31, 2024 | 17.58 Mn |
| Dec 31, 2023 | 20.84 Mn |
| Sep 30, 2023 | 23.23 Mn |
| Jun 30, 2023 | 27.38 Mn |
| Mar 31, 2023 | 32.80 Mn |
| Dec 31, 2022 | 38.15 Mn |
| Sep 30, 2022 | 43.23 Mn |
| Jun 30, 2022 | 45.85 Mn |
| Mar 31, 2022 | 50.61 Mn |
| Dec 31, 2021 | 54.78 Mn |
| Sep 30, 2021 | 54.44 Mn |